Although non-significantly, H3K4me3 at ADRA2A promoter was also increased in AP-treated schizophrenia subjects (Δ = +135% vs matched controls, p = 0.072, Fig. 3A). The gene discussed is ADRA2A; the disease is schizophrenia.